3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Urothelial Cancer
1
Synovitis, Pigmented Villonodular
1
Solid Tumor
1
Skin Neoplasms
1
Rectal Neoplasms
1
Polyps
1
Patient Satisfaction
1
Pancreatitis
1
Pancreatic Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Glioma
1
Diverticulosis, Colonic
1
Choledocholithiasis
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Carcinoma
1
Brain Neoplasms
1
Brain Diseases
1
Anxiety Disorders
1
Interventions
ulixertinib
1
tislelizumab
1
talazoparib
1
serabelisib
1
sapanisertib
1
pembrolizumab
1
olaparib
1
mirdametinib
1
lenvatinib
1
erdafitinib
1
crenigacestat
1
atezolizumab
1
Ramucirumab
1
Paclitaxel
1
PM 01183
1
Injections
1
IFL protocol
1
Gemcitabine
1
Bosentan
1
BID protein, human
1
Appointments and Schedules
1
1-dodecylpyridoxal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Solid Tumor
×
Midazolam
×
Clear all
No trials found.